• bryndos@fedia.io
      link
      fedilink
      arrow-up
      0
      ·
      11 days ago

      Why the fuck not?

      10 billion of those cunts now, it seems likely that overpopulation is at least slightly exacerbated by medical research.

      There should be plenty to spare for them to experiment on their own kind.

      • candyman337@lemmy.world
        link
        fedilink
        English
        arrow-up
        0
        ·
        edit-2
        11 days ago

        Literally the rhetoric that the Nazis used as an excuse to experiment on Jews in concentration camps

        • bryndos@fedia.io
          link
          fedilink
          arrow-up
          0
          ·
          11 days ago

          I don’t know much about nazis but I thought an important part of their rhetoric was to draw distinctions between types of human.

          So they’d not see “10bn humans”, they’d see maybe 100m aryan and 9.9bn “untermensch”; the latter being equivalent to rats available to be experimented on.

          I just find rats to be much more preferable, pleasant and considerate creatures than humans. I see humans as a single tier of unterratten; totally different hierarchcy.

          • lime!@feddit.nu
            link
            fedilink
            English
            arrow-up
            0
            ·
            11 days ago

            so how do you choose which humans to experiment on? bearing in mind that any sort of incentive will automatically select for a particular subset, and randomness will “obviously” need to exclude a particular subset

            • bryndos@fedia.io
              link
              fedilink
              arrow-up
              0
              ·
              10 days ago

              A researcher should offer a sufficient compensation package to get enough volunteers after explaining the risks. They should get independent medical advice too.

              They can still randomize within the volunteers with treatment / placebo, and maybe use quotas, but they’d just have to extend their trial period until they’d achieved a measurably representative treatment and control group and enough volunteers to test the hypothesis to the required level.

              This type of non-random sampling may very well have to be done anyway, for example if they needed the power to test efficacy and safety in all the potential dug interactions or co-morbidity scenarios. Not to mention any diagnosis requirement will also screen the sample which could be influenced by health care system resources and policies, not necessarily pure morbidity. So I think they can deal with non-random sampling in med research perfectly well.

              • anton@lemmy.blahaj.zone
                link
                fedilink
                English
                arrow-up
                0
                arrow-down
                1
                ·
                10 days ago

                A researcher should offer a sufficient compensation package to get enough volunteers after explaining the risks.

                So the poor and desperate.